For weight management, Medicare's new GLP-1 Bridge demonstration starts July 1, 2026, for adults age 18+ with BMI 27 plus prediabetes, prior heart attack, prior stroke, or symptomatic peripheral artery disease
Long-Term Effects: The long-term safety of BPC 157 is not yet fully understood, making it essential to approach with caution
Their ability to provide rapid weight loss while managing blood sugar levels has garnered attention and increased their popularity
Phase 3: Maintenance (lifelong) The long-term goal is to maintain your significant weight loss using the optimal dose that works well for you
Weight loss alone does not fully capture the biochemical adaptations occurring during prolonged GLP-1RA therapy, particularly those related to substrate redistribution, redox balance, and micronutrient-dependent metabolic processes
Hydrate well: Drinking plenty of water can help mitigate nausea and support your digestive system